A prevalence study and description of alli use by patients with eating disorders.
OBJECTIVE
This study examined the frequency and characteristics of alli use among patients in eating disorder treatment facilities.


METHODS
Patients from five treatment centers completed the Survey of Eating and Related Behaviors. Diagnoses were determined from survey responses.


RESULTS
Of 417 survey respondents, 26 (6.2%) reported a history of alli use. Of those, 15 (57.7%) met criteria for an eating disorder, including one of 29 patients (3.4%) with anorexia nervosa binge-purge subtype, six of 66 patients (9.1%) with full or subthreshold bulimia nervosa, four of 49 (8.2%) with binge eating disorder, one of six (16.7%) with purging disorder, and three of 80 (3.8%) with an eating disorder not otherwise specified.


CONCLUSIONS
The results of this survey suggest that patients with eating disorders use alli, albeit relatively uncommonly. Therefore, it is worthwhile for clinicians to inquire about alli use when evaluating or treating these patients in any clinical setting.
Neuropsychiatric Research Institute, Fargo, North Dakota 58103, USA. ksteffen@nrifargo.com
Kristine J
KJ
Steffen
James E
JE
Mitchell
Daniel
D
le Grange
Scott J
SJ
Crow
Evelyn
E
Attia
Cynthia M
CM
Bulik
Jocilyn E
JE
Dellava
Ovidio
O
Bermudez
Ann L
AL
Erickson
Ross D
RD
Crosby
Vidhu P
VP
Bansal-Dev
D019440:Anti-Obesity Agents / Q000008:administration & dosage; D005247:Feeding Behavior / Q000523:psychology*; D001068:Feeding and Eating Disorders / Q000523:psychology*; D005260:Female; D006306:Health Surveys; D006801:Humans; D007783:Lactones / Q000008:administration & dosage*; D000077403:Orlistat
D019440:Anti-Obesity Agents; D007783:Lactones; D000077403:Orlistat